• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:罗英,申潜,阮昊,蔡超慧,洪利娅.流通池法测定奥美拉唑肠溶胶囊溶出度[J].中国现代应用药学,2021,38(14):1704-1707.
LUO Ying,SHEN Qian,RUAN Hao,CAI Chaohui,HONG Liya.Dissolution Determination of Omeprazole Enteric Capsules by Flow-through Cell Method[J].Chin J Mod Appl Pharm(中国现代应用药学),2021,38(14):1704-1707.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1418次   下载 725 本文二维码信息
码上扫一扫!
分享到: 微信 更多
流通池法测定奥美拉唑肠溶胶囊溶出度
罗英1, 申潜1, 阮昊1, 蔡超慧2, 洪利娅1
1.浙江省食品药品检验研究院, 国家药监局仿制药评价关键技术重点实验室, 杭州 310052;2.浙江工业大学, 杭州 310014
摘要:
目的 建立奥美拉唑肠溶胶囊溶出度测定方法,并考察不同厂家产品溶出度。方法 采用流通池的开环系统,以pH 1.2盐酸溶液、pH 6.0磷酸盐缓冲液、pH 6.2磷酸盐缓冲液为溶出介质,流速为4 mL·min–1,在规定时间点取样后采用HPLC测定奥美拉唑溶出度。考察奥美拉唑肠溶胶囊仿制制剂与参比制剂的溶出情况,并通过计算相似因子(f2)评价其溶出曲线相似性。结果 国内26家企业中7家企业市售产品与参比制剂的溶出曲线相似,其余均存在差异。结论 该方法可用于奥美拉唑肠溶胶囊溶出度测定,对于质量控制具有重要的指导意义;仿制制剂与参比制剂体外溶出存在差异,为进一步改进产品工艺和评价仿制药一致性提供重要的实验依据。
关键词:  奥美拉唑肠溶胶囊  流通池法  溶出曲线  相似因子
DOI:10.13748/j.cnki.issn1007-7693.2021.14.007
分类号:R917
基金项目:浙江省药品监督管理局科技计划项目(2020006)
Dissolution Determination of Omeprazole Enteric Capsules by Flow-through Cell Method
LUO Ying1, SHEN Qian1, RUAN Hao1, CAI Chaohui2, HONG Liya1
1.Zhejiang Institute for Food and Drug Control, NMPA Key Laboratory for Core Technology of Generic Drug Evaluation, Hangzhou 310052, China;2.Zhejiang University of Technology, Hangzhou 310014, China
Abstract:
OBJECTIVE To develop a flow-through cell method for the dissolution test of omeprazole enteric capsules and compare the dissolution behaviors of omeprazole enteric capsules from different manufacturers. METHODS An open-loop mode of flow-through cell apparatus was employed, with pH 1.2 hydrochloric acid solution, pH 6.0 phosphate buffer solution and pH 6.2 phosphate buffer solution as the dissolution medium, and the flow rate was 4 mL·min-1, the samples were collected at the specified time point and determined by HPLC. The dissolution profiles of omeprazole enteric capsules from different pharmaceutical manufacturers were determined, and the dissolution curves of consistency were evaluated by calculating the similarity factor(f2). RESULTS The dissolution profiles of the products from 7 domestic pharmaceutical manufacturers were similar to those of the reference listed drug(RLD). The dissolution curves of the rest of the manufacturers' products were different with the RLD. CONCLUSION The method which can be used to determine the dissolution of omeprazole enteric capsules is instructive to the quality control of the products. There is difference of in vitro dissolution behavior between the generic preparations and the RLD, which provides assistance for further optimizing manufacturing process and evaluating the consistency of generic drugs.
Key words:  omeprazole enteric capsules  flow-through cell method  dissolution curves  similarity factor
扫一扫关注本刊微信